1. Surgical management of rheumatoid arthritis;Mowat, A.;Clin Rheum Dis,1978
2. Organisation and development of combined care in the outpatient clinic. In: Combined care ofthe rheumatic patient;Bird, H.A.; le Gallez, P.; Hill, J.,1985
3. Accepted SMarch,1987
4. Drugs which exacerbate Parkinson's disease include the phenothiazines (for example, chlorpromazine), the butyrophenones (for example, haloperidol), and the thioxanthenes (for example, chlorprothixene). There is an antagonism between levodopa and pyridoxine, although this does not occur if a dopadecarboxylase inhibitor is also given
5. Several groups of drugs are used to treat Parkinson's disease. Anticholinergic drugs-Used in the early stages of the disease anticholinergic drugs may delay the need to give levodopa drugs and hence be of clinical value, but in the late stages of the disease they should be used cautiously because they may impair memory or hasten dementia. The drugs include the following (see the British National Formulary for the precise formulations and dosages): -benzhexol (Artane, Bentex, Broflex) up to 5 mg three times a day, -orphenadrine (Biorphen, Disipal) up to 100 mg four times a day, -benztropine (Cogentin) up to 2 mg three times a day, -methixene (Tremonil) up to 10 mg three times a day, -procyclidine (Arpicolin, Kemadrin) up to 10 mg three times a day